SJF 1528 - ≥98%(HPLC) , CAS No.2230821-38-0

CAS: 2230821-38-0 Cat. No.: S287968 Peso molecular: 1030.61 PubChem CID: 135157151
Disponible para pedir
GRADE & PURITY ≥98%(HPLC)
Synonyms
(2S,4R)-1-((S)-2-(2-(2-(2-(4-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6- yl)phenoxy)ethoxy)ethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
 ·  off list, applied to all prices below.
Size
Estado
Price
Qty
5mg
S287968-5mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
710,90US$
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥98%(HPLC) for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Specifications

Sinónimos
(2S, 4R)-1-((S)-2-(2-(2-(2-(4-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6- yl)phenoxy)ethoxy)ethoxy)acetamido)-3, 3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Especificaciones y pureza
≥98%(HPLC)
Mecanismos bioquímicos y fisiológicos
Potent EGFR Degrader (DC50values are 39.2 nM for wild-type EGFR in OVCAR8 cells and 736 nM for Exon20Ins mutated EGFR in HeLa cells). Also degrades HER2. Comprises the EGFR inhibitorlapatinib joined by a linker to a von Hippel-Lindau (VHL) recruiting liga
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Pureza
≥98%(HPLC)
Nombres e identificadores
Sonrisas canónicasCC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)COCCOCCOC4=CC=C(C=C4)C5=CC6=C(C=C5)N=CN=C6NC7=CC(=C(C=C7)OCC8=CC(=CC=C8)F)Cl)O
IUPAC Name(2S,4R)-1-[(2S)-2-[[2-[2-[2-[4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]phenoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
InChIKeyZSCOIFSUFMYZEZ-YSWDPXALSA-N
INCHI1S/C55H57ClFN7O8S/c1-34-50(73-33-61-34)38-10-8-35(9-11-38)28-58-53(67)47-27-42(65)29-64(47)54(68)51(55(2,3)4)63-49(66)31-70-21-20-69-22-23-71-43-16-12-37(13-17-43)39-14-18-46-44(25-39)52(60-32-59-46)62-41-15-19-48(45(56)26-41)72-30-36-6-5-7-40(57)24-36/h5-19,24-26,32-33,42,47,51,65H,20-23,27-31H2,1-4H3,(H,58,67)(H,63,66)(H,59,60,62)/t42-,47+,51-/m1/s1
Isómeros SMILES CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOC4=CC=C(C=C4)C5=CC6=C(C=C5)N=CN=C6NC7=CC(=C(C=C7)OCC8=CC(=CC=C8)F)Cl)O
PubChem CID 135157151
Peso molecular 1030.61

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propiedades químicas y físicas
SolubilidadSolvent:DMSO, Max Conc. mg/mL: 103.06, Max Conc. mM: 100
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Artículos relacionados

AEE788 (NVP-AEE788) - ≥97% , Vascular endothelial growth factor receptor 1 inhibitor, CAS No.497839-62-0
ZM 306416 - Moligand™, ≥98% , Inhibitor of epidermal growth factor receptor;Inhibitor of fms related receptor tyrosine kinase 1;Inhibitor of kinase insert domain receptor, CAS No.690206-97-4
SJF 1521 - ≥98%(HPLC) , CAS No.2230821-40-4
RAF265 (CHIR-265) - Moligand™, ≥98% , Vascular endothelial growth factor receptor 2 inhibitor, CAS No.927880-90-8
PD153035 - ≥98% , CAS No.153436-54-5
PF 6274484 - ≥98%(HPLC) , CAS No.1035638-91-5
Ki8751 - ≥98% , CAS No.228559-41-9
SU1498 - ≥98%(HPLC) , CAS No.168835-82-3
VEGFR2 Kinase Inhibitor I - Moligand™, ≥98%, (including isomers) , Inhibitor of kinase insert domain receptor, CAS No.15966-93-5
AV 412 - ≥98%(HPLC) , CAS No.451492-95-8
AAL 993 - ≥98% , CAS No.269390-77-4
BMS 605541 - ≥98%(HPLC) , CAS No.639858-32-5
HKI 357 - ≥98%(HPLC) , CAS No.848133-17-5
KRN-633 - Moligand™, ≥97% , Vascular endothelial growth factor receptor inhibitor, CAS No.286370-15-8
PD168393 - ≥98% , CAS No.194423-15-9
AG 99 - ≥99%(HPLC) , CAS No.122520-85-8
PD 174265 - Moligand™, ≥98% , Inhibitor of epidermal growth factor receptor, CAS No.216163-53-0
VEGFR2 kinase inhibitor IV - Moligand™, ≥95% , Inhibitor of kinase insert domain receptor, CAS No.216661-57-3
Tyrphostin 47 - ≥99% , CAS No.122520-86-9
Src/EGFR inhibitor, CAS No.131023-24-0
Brivanib (BMS-540215) - Moligand™, ≥98% , Vascular endothelial growth factor receptor inhibitor, CAS No.649735-46-6
Brivanib Alaninate (BMS-582664) - Moligand™, ≥95% , Vascular endothelial growth factor receptor inhibitor, CAS No.649735-63-7
CGP 52411 , CAS No.145915-58-8
CO-1686 (AVL-301) - Moligand™, ≥99% , Epidermal growth factor receptor erbB1 inhibitor, CAS No.1374640-70-6
CUDC-101 - Moligand™, ≥98% , Histone deacetylase inhibitor, CAS No.1012054-59-9
EGFR inhibitor - Moligand™, ≥98% , Inhibitor of epidermal growth factor receptor, CAS No.879127-07-8
EGFR-IN-5 - ≥98% , CAS No.2225887-26-1
EGFR-IN-7 - ≥98% , CAS No.2267329-76-8
EGFR/ErbB-2/ErbB-4 inhibitor-2 - Moligand™, ≥98% , Inhibitor of epidermal growth factor receptor;Inhibitor of erb-b2 receptor tyrosine kinase 2, CAS No.179248-61-4
EGFR inhibitor - Moligand™, 10mM in DMSO , Inhibitor of epidermal growth factor receptor, CAS No.879127-07-8
JBJ-03-142-02 - ≥98%(HPLC) , CAS No.2068806-31-3
Ramucirumab (anti-VEGFR2) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to VEGFR2, >95%, Human IgG1, Antibody of kinase insert domain receptor
SU4312 - Moligand™, ≥98% , Inhibitor of kinase insert domain receptor, CAS No.5812-07-7
UNC0064-12 (VEGFR-2-IN-5) - ≥98% , CAS No.1430089-64-7
VEGFR Tyrosine Kinase Inhibitor II - Moligand™, ≥98% , Inhibitor of kinase insert domain receptor, CAS No.269390-69-4
VEGFR2 Kinase Inhibitor I - Moligand™, 10mM in DMSO , Inhibitor of kinase insert domain receptor, CAS No.15966-93-5
Panitumumab (anti-EGFR) - Primary antibody, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to EGFR, >95%, Human IgG2SA, Antibody of epidermal growth factor receptor
Cetuximab (anti-EGFR) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to ERBB1/EGFR/HER1, >95%, Human IgG1, Antibody of epidermal growth factor receptor
Necitumumab (anti-EGFR) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to EGFR, >95%, Human IgG1, Antibody of epidermal growth factor receptor
EGFR inhibitor 57 - Moligand™ , Allosteric modulator of epidermal growth factor receptor, CAS No.E610080
Nimotuzumab (anti-EGFR) - Primary antibody, specific to EGFR, >95%, Human IgG1, INHIBITOR of Epidermal growth factor receptor erbB1 inhibitor
EGFR Mouse mAb - Primary antibody, specific to EGFR, IgG2b

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.